We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The HHS has awarded a $97 million contract to sanofi pasteur to support the development of cell culture-based influenza vaccines, an advanced type of flu vaccine the agency hopes can be manufactured faster and in larger volumes than traditional egg-based vaccines.
Shifting some categories of Medicare Part B drugs to Part D could fuel competitive pressures on pharmaceutical pricing, but the HHS does not recommend consolidating coverage of the products until the Medicare prescription drug benefit has had a chance to get up and running, a new report says.
Although shifting some Medicare Part B drugs to Part D could stoke competitive pressures on pharmaceutical pricing, the HHS does not recommend consolidating the coverage until the Medicare prescription drug benefit has had a chance to get up and running, according to a new report.
HHS Secretary Michael Leavitt has started shaping his senior leadership team, announcing six key appointments to the agency this week, including the creation of a senior health policy position.
Former HHS Secretary Tommy Thompson has accepted two positions in the private sector — one with law firm Akin Gump Strauss and another with consulting firm Deloitte & Touche, the companies announced March 9.
The best way for drug and device manufacturers to receive the fastest possible coverage decisions from the Centers for Medicare & Medicaid Services (CMS) is to submit all relevant information on their products during the initial request for a Medicare national coverage determination (NCD), the agency states in a new draft guidance.
The Justice Department is investigating GlaxoSmithKline’s (GSK) use of nominal pricing arrangements to determine whether the pricing strategy violates Medicaid price-reporting rules.
The Senate confirmed Michael Leavitt as secretary of HHS Jan. 26. The confirmation, which came by voice vote, occurred one day after the Senate Finance Committee unanimously recommended his nomination be approved.